OneMedNet Reports 111% Revenue Growth to $1.36M in 2025, Narrows Net Loss
ONMD has more than doubled off its 52-week low of $0.3 on light trading volume (0.1× avg).
Summary
OneMedNet Corporation reported its 2025 annual financial results, showing a 111% year-over-year revenue increase to $1.36 million, driven by increased iRWD data deliveries. The company posted a net loss per share of $(0.06), but significantly narrowed its total net loss to $(2.801) million from $(10.129) million in 2024, largely due to fair value and debt restructuring gains. This annual report provides a crucial update on the company's financial health and strategic shift towards iRWD data services. While the company remains unprofitable with a negative gross margin, the strong revenue growth and improved net loss are notable. Traders will be watching for continued operational improvements and sustained growth in its core data services.
At the time of this announcement, ONMD was trading at $0.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.5M. The 52-week trading range was $0.30 to $4.22. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.